To be Honest their half yearly report will not 'boost' the SP. What ya'll need to realise is this is a company in very early stages, with little income but a lot of expenses. The truth of the fact is it costs a lot to research, test and produce these tests in their current form. It's all done out of pocket. Until they commercialise their products any half yearly or yearly report will be average at best. All IMO, don't be coming at me or defending BD1 because I am as balls deep into BARD1 than any of ya.
Half Yearly Report, page-6
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IIQ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
50.0¢ |
Change
0.005(1.01%) |
Mkt cap ! $55.76M | |||
| Open | High | Low | Value | Volume |
| 48.5¢ | 50.0¢ | 48.0¢ | $19.61K | 40.61K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2083 | 48.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 50.0¢ | 18735 | 3 |
View Market Depth
| Last trade - 16.10pm 30/09/2024 (20 minute delay) ? |
| IIQ (ASX) Chart |